Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  261,907 results for ""Immunotherapy""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Immunotherapy.
Research Starter

Immunotherapy.

  • Cancers treated: Breast cancer, lung cancer, melanoma, cervical cancer, leukemias, lymphomas, myelomas, prostate cancer, colorectal cancer, and ovarian cancer; others ... More
  • Salem Press Encyclopedia of Health, 2022. 3p.
Academic Journal

CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours.

  • Authors : Tang HKC; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.; Wang B

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/pathology; Humans

  • Source: Cells [Cells] 2023 Jun 08; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
Academic Journal

Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.

  • Authors : Rivera Z; Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, Chicago, IL 60612, USA.; Escutia C

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/genetics ; Neuroblastoma*/Neuroblastoma*/Neuroblastoma*/therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 May 09; Vol. 24 (10). Date of Electronic Publication: 2023 May 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Tumor therapeutic response monitored by telemetric temperature sensing, a preclinical study on immunotherapy and chemotherapy.

  • Authors : Shao Q; Department of Mechanical Engineering, University of Minnesota, Minneapolis, USA. .; Lundgren M

Subjects: Immunotherapy* ; Melanoma*/Melanoma*/Melanoma*/pathology; Animals

  • Source: Scientific reports [Sci Rep] 2023 May 12; Vol. 13 (1), pp. 7727. Date of Electronic Publication: 2023 May 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.

  • Authors : Huang S; The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/Receptors, Antigen, T-Cell*/genetics; Humans

  • Source: Molecular cancer [Mol Cancer] 2023 May 06; Vol. 22 (1), pp. 80. Date of Electronic Publication: 2023 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

×
Academic Journal

The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.

  • Authors : Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .; Brentjens R

Subjects: Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy; Humans

  • Source: Journal of translational medicine [J Transl Med] 2023 Apr 22; Vol. 21 (1), pp. 275. Date of Electronic Publication: 2023 Apr 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Potent Apoptosis Induction by a Novel Trispecific B7-H3xCD16xTIGIT 2+1 Common Light Chain Natural Killer Cell Engager.

  • Authors : Ulitzka M; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Peter-Grünberg-Str. 4, 64287 Darmstadt, Germany.; Harwardt J

Subjects: Killer Cells, Natural* ; Immunotherapy*; Antibodies, Monoclonal

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 04; Vol. 29 (5). Date of Electronic Publication: 2024 Mar 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer.

  • Authors : Huang H; Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.

Subjects: Immunotherapy* ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics; Humans

  • Source: Journal of translational medicine [J Transl Med] 2024 Feb 28; Vol. 22 (1), pp. 211. Date of Electronic Publication: 2024 Feb 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis.

  • Authors : Li Y; Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. .; Xiao H

Subjects: Rhinitis, Allergic*/Rhinitis, Allergic*/Rhinitis, Allergic*/diagnosis ; Rhinitis, Allergic*/Rhinitis, Allergic*/Rhinitis, Allergic*/therapy ; Sublingual Immunotherapy*/Sublingual Immunotherapy*/Sublingual Immunotherapy*/methods

  • Source: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2024 Feb 11; Vol. 23 (1), pp. 52-58. Date of Electronic Publication: 2024 Feb 11.Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101146178 Publication Model: Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

Galectin-3 and cancer immunotherapy: a glycobiological rationale to overcome tumor immune escape.

  • Authors : Scafetta G; Pathology Research Laboratory St, Andrea University Hospital, Via Di Grottarossa 1035, 00189, Rome, Italy.; D'Alessandria C

Subjects: Galectin 3*/Galectin 3*/Galectin 3*/genetics ; Immunotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 06; Vol. 43 (1), pp. 41. Date of Electronic Publication: 2024 Feb 06.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

×
Editorial & Opinion

State-of-the-Art Cancer Immunotherapies.

  • Authors : Nagase H; Department of Parasitology, Shinshu University School of Medicine 3-1-1, Asahi, Matsumoto 390-8621, Japan.; Kato T

Subjects: Immunotherapy* ; Neoplasms*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 22; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
  • 1-10 of  261,907 results for ""Immunotherapy""